For adults aged 50 years or older, an investigational mRNA-based vaccine is superior to standard-dose vaccines for preventing influenza.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results